Barbara Goezinne, the Netherlands’ Vice Minister of Health, Curative Care, and her delegation meets Karnataka Health Minister Dinesh Gundu Rao at Bengaluru’s Centre for Cellular and Molecular Platforms (C-CAMP) on Thursday.
Credit: C-CAMP
Bengaluru: A delegation from the Dutch Ministry of Health visited Bengaluru’s Centre for Cellular and Molecular Platforms (C-CAMP) on Thursday to explore potential collaborations in AI-powered healthtech and pharmaceutical innovation.
During their visit, they met Karnataka Health Minister Dinesh Gundu Rao to discuss aligning the Netherlands’ public health system with the state government’s initiatives.
A key focus was establishing an Innovation Bridge anchored by C-CAMP as part of a bilateral partnership between the two governments.
Barbara Goezinne, the Netherlands’ Vice Minister of Health, Curative Care, and her delegation expressed interest in deploying AI-based healthtech solutions already active in Karnataka and India. Their discussions centered on remote patient monitoring, telemedicine, medical diagnostics, and AI-powered drug development. The delegation also interacted with teams behind key innovations.
Barbara praised C-CAMP’s efforts to make cutting-edge medical technology more affordable. "The innovation walk was an opportunity to meet inspiring founders behind these innovations. We are committed to working together on labour-saving medical solutions to support healthcare professionals," she said.
Several digital health innovations supported by C-CAMP have been integrated into Karnataka’s public health system, enhancing services in ophthalmology, maternal and child care, immunisation and remote patient monitoring, Rao noted.
"The state government has been working closely with C-CAMP to develop and scale impactful innovations. It’s great to have visitors from the Netherlands — we can learn from your experiences and explore future collaborations,” he added.
C-CAMP CEO-Director Dr Taslimarif Saiyed highlighted the delegation’s interest in the institution’s work, which includes more than 80 AI-enabled healthcare solutions ready for large-scale deployment.
"One of our translational projects for sepsis was licensed to Dutch biotech firm Survivex over a year ago. We also have ongoing collaborations with Dutch institutions such as Utrecht and Leiden, as well as industry partners," he said.